| RS2512133290 |
KDM4B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 65 |
| RS2512147217 |
KDM4B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2512151147 |
KDM4B
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 65 |
| RS2512164434 |
ELANE
|
Health Risk |
Conflicting classifications of pathogenicity |
Cyclical neutropenia, Neutropenia |
| RS2512164486 |
ELANE
|
Health Risk |
Likely pathogenic |
Cyclical neutropenia, Neutropenia |
| RS2512164490 |
ELANE
|
Health Risk |
Pathogenic |
Cyclical neutropenia, Neutropenia |
| RS2512164539 |
ELANE
|
Health Risk |
Likely pathogenic |
— |
| RS2512164548 |
ELANE
|
Health Risk |
Likely pathogenic |
Neutropenia, severe congenital |
| RS2512164614 |
ELANE
|
Health Risk |
Pathogenic |
Neutropenia, severe congenital |
| RS2512165572 |
ELANE
|
Health Risk |
Likely pathogenic |
Neutropenia, severe congenital |
| RS2512166678 |
KDM4B
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 65 |
| RS2512167144 |
GPR179
|
Health Risk |
Likely pathogenic |
— |
| RS2512168136 |
ELANE
|
Health Risk |
Likely pathogenic |
Decreased total neutrophil count, Decreased total neutrophil count |
| RS2512168309 |
ELANE
|
Health Risk |
Likely pathogenic |
— |
| RS2512168318 |
ELANE
|
Health Risk |
Likely pathogenic |
Cyclical neutropenia, Cyclical neutropenia |
| RS2512168552 |
ELANE
|
Health Risk |
Pathogenic |
Cyclical neutropenia, Neutropenia |
| RS2512168653 |
ELANE
|
Health Risk |
Likely pathogenic |
Cyclical neutropenia, Neutropenia |
| RS2512168691 |
ELANE
|
Health Risk |
Likely pathogenic |
Neutropenia, severe congenital |
| RS2512169227 |
ELANE
|
Health Risk |
Pathogenic |
Cyclical neutropenia, Neutropenia |
| RS2512169267 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS2512169449 |
ELANE
|
Health Risk |
Likely pathogenic |
Cyclical neutropenia, Cyclical neutropenia |
| RS2512170410 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS2512175710 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS2512176050 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS2512176243 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS2512176863 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS2512177578 |
CFD
|
Health Risk |
Likely pathogenic |
— |
| RS2512178559 |
TCF4
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS2512178640 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2512178673 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2512178695 |
TCF4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512179036 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2512182702 |
SEMA6B
|
Health Risk |
Pathogenic |
— |
| RS2512182790 |
SEMA6B
|
Health Risk |
Pathogenic |
— |
| RS2512182831 |
SEMA6B
|
Health Risk |
Pathogenic |
Epilepsy, progressive myoclonic |
| RS2512182865 |
SEMA6B
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2512183344 |
SEMA6B
|
Health Risk |
Likely pathogenic |
Epilepsy, progressive myoclonic |
| RS2512184365 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512205352 |
NDUFS7
|
Health Risk |
Pathogenic |
— |
| RS2512206013 |
NDUFS7
|
Health Risk |
Likely pathogenic |
— |
| RS2512210872 |
NDUFS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 3 |
| RS2512219546 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2512221367 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS2512221397 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512221442 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512223966 |
C3
|
Health Risk |
Likely pathogenic |
— |
| RS2512224098 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512224264 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS2512224441 |
GAMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Cerebral creatine deficiency syndrome |
| RS2512224776 |
GAMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Cerebral creatine deficiency syndrome |
| RS2512224786 |
GAMT
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512224917 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512225602 |
GAMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS2512226322 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512226967 |
TCF4
|
Health Risk |
Pathogenic |
Corneal dystrophy, Fuchs endothelial |
| RS2512228786 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512228836 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS2512228920 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512229031 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS2512229116 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS2512229150 |
GAMT
|
Health Risk |
Pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512229186 |
GAMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Cerebral creatine deficiency syndrome |
| RS2512229196 |
GAMT
|
Health Risk |
Pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512229344 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2512233215 |
C3
|
Health Risk |
Likely pathogenic |
— |
| RS2512233517 |
C3
|
Health Risk |
Likely pathogenic |
Complement component 3 deficiency, Complement component 3 deficiency |
| RS2512236070 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512247702 |
C3
|
Health Risk |
Pathogenic |
— |
| RS2512251370 |
TCF4
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512254213 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2512257929 |
C3
|
Health Risk |
Pathogenic |
— |
| RS2512260688 |
C3
|
Health Risk |
Pathogenic |
— |
| RS2512262130 |
C3
|
Health Risk |
Pathogenic |
— |
| RS2512262623 |
C3
|
Health Risk |
Pathogenic |
— |
| RS2512263954 |
C3
|
Health Risk |
Pathogenic |
— |
| RS2512264048 |
C3
|
Health Risk |
Pathogenic |
— |
| RS2512264297 |
C3
|
Health Risk |
Pathogenic |
— |
| RS2512267009 |
C3
|
Health Risk |
Likely pathogenic |
— |
| RS2512270762 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS2512273417 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS2512275935 |
ZBTB7A
|
Health Risk |
Likely pathogenic |
— |
| RS2512277057 |
FZR1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 109, Developmental and epileptic encephalopathy 109 |
| RS2512277062 |
FZR1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 109, Developmental and epileptic encephalopathy 109 |
| RS2512282556 |
KISS1R
|
Health Risk |
Likely pathogenic |
— |
| RS2512284473 |
KISS1R
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 8 without anosmia, Hypogonadotropic hypogonadism 8 without anosmia |
| RS2512285101 |
INSR
|
Health Risk |
Pathogenic |
— |
| RS2512293384 |
FZR1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512294848 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2512296129 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2512310700 |
ATP5F1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial disease, Inborn genetic diseases |
| RS2512317329 |
RAX2
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 11, Cone-rod dystrophy 11 |
| RS2512318480 |
RAX2
|
Health Risk |
Pathogenic |
— |
| RS2512328575 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS2512328838 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS2512343670 |
CREB3L3
|
Health Risk |
Pathogenic |
— |
| RS2512344317 |
DPP9
|
Health Risk |
Pathogenic |
Hatipoglu immunodeficiency syndrome, Hatipoglu immunodeficiency syndrome |
| RS2512353998 |
ABCA7
|
Health Risk |
Likely pathogenic |
ABCA7-related disorder, ABCA7-related disorder |
| RS2512358919 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS2512363368 |
INSR
|
Health Risk |
Likely pathogenic |
Leprechaunism syndrome, Gastric cancer |
| RS2512386644 |
LONP1
|
Health Risk |
Likely pathogenic |
— |